Required for Their Activation Survival of Anergic Anti-DNA B Cells , Yet Is TLR 9 Promotes Tolerance by Restricting Shlomchik

Nucleic acid–reactive B cells frequently arise in the bone marrow but are tolerized by mechanisms including receptor editing, functional anergy, and/or deletion. TLR9, a sensor of endosomal dsDNA, both promotes and regulates systemic autoimmunity in vivo, but the precise nature of its apparently contradictory roles in autoimmunity remained unclear. In this study, using the 3H9 anti-DNA BCR transgene in the autoimmune-prone MRL.Fas lpr mouse model of systemic lupus erythematosus, we identify the stages at which TLR9 contributes to establishing and breaking B cell tolerance. Although TLR9 is dispensable for L chain editing during B cell development in the bone marrow, TLR9 limits anti-DNA B cell life span in the periphery and is thus tolerogenic. In the absence of TLR9, anti-DNA B cells have much longer life spans and accumulate in the follicle, neither activated nor deleted. These cells retain some characteristics of anergic cells, in that they have elevated basal BCR signaling but impaired induced responses and downregulate their cell-surface BCR expression. In contrast, whereas TLR9-intact anergic B cells accumulate near the T/B border, TLR9-deficient anti-DNA B cells are somewhat more dispersed throughout the follicle. Nonetheless, in older autoimmune-prone animals, TLR9 expression specifically within the B cell compartment is required for spontaneous peripheral activation of anti-DNA B cells and their differentiation into Ab-forming cells via an extrafollicular pathway. Thus, TLR9 has paradoxical roles in regulating anti-DNA B cells: it helps purge the peripheral repertoire of autoreactive cells, yet is also required for their activation. A utoreactive BCRs arise as a result of V(D)J recombi-nation. As many as 55–75% of developing B cells display BCRs with measurable affinity for self-epitopes (1). Several self-tolerance mechanisms efficiently eliminate the majority of self-reactive BCR specificities before or shortly after entry into the mature B cell repertoire. These include editing of autoreactive BCRs through additional rounds of recombination at the L chain loci, deletion of autoreactive B cells, or the acquisition of a functionally unresponsive phenotype termed anergy (2, 3). Recently, we and others have shown that TLR9, an endosomal innate immune sensor of dsDNA (4), is required for formation of spontaneous anti-DNA autoantibodies in several in vivo mouse models of systemic lupus erythematosus (SLE) (5–10). These findings are consistent with a model in which autoreactive B cells in SLE break tolerance due to the unique ability of nucleic acid– containing self-Ags to coengage the BCR and one or more innate immune sensors of nucleic …

[1]  E. L. Luning Prak,et al.  B-Cell Tolerance Defects in the B6.Aec1/2 Mouse Model of Sjögren’s Syndrome , 2012, Journal of Clinical Immunology.

[2]  Idan Tamir,et al.  Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. , 2011, Immunity.

[3]  H. Wardemann,et al.  AutoimmunityTo Control Th17 Cells and Severe Production of Protective Self-Reactive IgM TLR9 in Peritoneal B-1b Cells Is Essential for , 2011 .

[4]  Sarah E. Ewald,et al.  Nucleic acid recognition by the innate immune system. , 2011, Annual review of immunology.

[5]  S. Akira,et al.  Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. , 2010, Journal of autoimmunity.

[6]  W. Thomas,et al.  Absence of SHIP-1 Results in Constitutive Phosphorylation of Tank-Binding Kinase 1 and Enhanced TLR3-Dependent IFN-β Production , 2010, The Journal of Immunology.

[7]  J. Shupe,et al.  TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus , 2010, The Journal of Immunology.

[8]  M. Rickels,et al.  RS rearrangement frequency as a marker of receptor editing in lupus and type 1 diabetes , 2008, The Journal of experimental medicine.

[9]  J. Casanova,et al.  IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. , 2008, Immunity.

[10]  Uri Hershberg,et al.  T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. , 2008, Immunity.

[11]  S. Gauld,et al.  B-cell anergy: from transgenic models to naturally occurring anergic B cells? , 2007, Nature Reviews Immunology.

[12]  D. Melamed,et al.  CpG DNA stimulates autoreactive immature B cells in the bone marrow , 2007, European journal of immunology.

[13]  M. Shlomchik,et al.  Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors. , 2007, Seminars in immunology.

[14]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[15]  J. Shupe,et al.  Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. , 2006, Immunity.

[16]  T. Winkler,et al.  Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE. , 2006, International immunology.

[17]  P. Courville,et al.  Role of TLR9 in Anti-Nucleosome and Anti-DNA Antibody Production in lpr Mutation-Induced Murine Lupus1 , 2006, The Journal of Immunology.

[18]  E. L. Prak,et al.  Exogenous and Endogenous TLR Ligands Activate Anti-Chromatin and Polyreactive B Cells1 , 2006, The Journal of Immunology.

[19]  J. Erikson,et al.  The regulation and activation of lupus‐associated B cells , 2005, Immunological reviews.

[20]  J. Cyster,et al.  Requirements for Follicular Exclusion and Competitive Elimination of Autoantigen-Binding B Cells1 , 2004, The Journal of Immunology.

[21]  Yoram Louzoun,et al.  Editing Anti-DNA B Cells by Vλx , 2004, The Journal of experimental medicine.

[22]  T. Manser,et al.  Progressive Surface B Cell Antigen Receptor Down-Regulation Accompanies Efficient Development of Antinuclear Antigen B Cells to Mature, Follicular Phenotype1 , 2004, The Journal of Immunology.

[23]  F. Finkelman,et al.  The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. , 2002, Immunity.

[24]  M. Madaio,et al.  Fas/Fas Ligand Deficiency Results in Altered Localization of Anti-Double-Stranded DNA B Cells and Dendritic Cells1 , 2001, The Journal of Immunology.

[25]  R. Hardy,et al.  Functional Consequences of the Developmental Arrest and Follicular Exclusion of Anti-Double-Stranded DNA B Cells1 , 2000, The Journal of Immunology.

[26]  C. Sokol,et al.  MRL-lpr/lpr Mice Exhibit a Defect in Maintaining Developmental Arrest and Follicular Exclusion of Anti–double-stranded DNA B Cells , 1999, The Journal of experimental medicine.

[27]  J. Allison,et al.  Repression of B7.2 on Self-reactive B Cells Is Essential to Prevent Proliferation and Allow Fas-mediated Deletion by CD4+ T Cells , 1998, The Journal of experimental medicine.

[28]  M. Shlomchik,et al.  A disease-related rheumatoid factor autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease , 1996, The Journal of experimental medicine.

[29]  J. Cyster,et al.  Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. , 1995, Immunity.

[30]  M. Radic,et al.  Light chain contribution to specificity in anti-DNA antibodies. , 1995, Journal of immunology.

[31]  C. Kuntz,et al.  Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus , 1995, The Journal of experimental medicine.

[32]  R. Hardy,et al.  The site and stage of anti-DNA B-cell deletion , 1995, Nature.

[33]  R. Hardy,et al.  Deletion and editing of B cells that express antibodies to DNA. , 1994, Journal of immunology.

[34]  M. Cancro,et al.  Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. , 1993, Journal of immunology.

[35]  W. Anderson,et al.  Residues that mediate DNA binding of autoimmune antibodies. , 1993, Journal of immunology.

[36]  S. Camper,et al.  Receptor editing: an approach by autoreactive B cells to escape tolerance , 1993, The Journal of experimental medicine.

[37]  M. Monestier,et al.  Monoclonal autoantibodies to subnucleosomes from a MRL/Mp(-)+/+ mouse. Oligoclonality of the antibody response and recognition of a determinant composed of histones H2A, H2B, and DNA. , 1992, Journal of immunology.

[38]  R. Hardy,et al.  Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice , 1991, Nature.

[39]  D. Pisetsky,et al.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation , 1990, The Journal of experimental medicine.

[40]  D. Pisetsky,et al.  Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Bouvet,et al.  Restricted heterogeneity of polyclonal rheumatoid factors. , 1987, Arthritis & Rheumatism.

[42]  D. Melamed,et al.  B cell receptor editing in tolerance and autoimmunity. , 2007, Frontiers in bioscience : a journal and virtual library.

[43]  H. Ploegh,et al.  Predominant Autoantibody Production by Early Human B Cell Precursors , 2003 .